健康与代谢紊乱中的鞘脂和脂蛋白
Sphingolipids and Lipoproteins in Health and Metabolic Disorders.
作者信息
Iqbal Jahangir, Walsh Meghan T, Hammad Samar M, Hussain M Mahmood
机构信息
Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, NY 11203, USA; King Abdullah International Medical Research Center, MNGHA, Al Ahsa 31982, Saudi Arabia.
Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, NY 11203, USA.
出版信息
Trends Endocrinol Metab. 2017 Jul;28(7):506-518. doi: 10.1016/j.tem.2017.03.005. Epub 2017 Apr 24.
Abstract
Sphingolipids are structurally and functionally diverse molecules with significant physiologic functions and are found associated with cellular membranes and plasma lipoproteins. The cellular and plasma concentrations of sphingolipids are altered in several metabolic disorders and may serve as prognostic and diagnostic markers. Here we discuss various sphingolipid transport mechanisms and highlight how changes in cellular and plasma sphingolipid levels contribute to cardiovascular disease, obesity, diabetes, insulin resistance, and nonalcoholic fatty liver disease (NAFLD). Understanding of the mechanisms involved in intracellular transport, secretion, and extracellular transport may provide novel information that might be amenable to therapeutic targeting for the treatment of various metabolic disorders.
摘要
鞘脂是结构和功能多样的分子，具有重要的生理功能，与细胞膜和血浆脂蛋白相关。鞘脂的细胞内和血浆浓度在几种代谢紊乱中会发生改变，可作为预后和诊断标志物。在此，我们讨论各种鞘脂转运机制，并强调细胞内和血浆鞘脂水平的变化如何导致心血管疾病、肥胖、糖尿病、胰岛素抵抗和非酒精性脂肪性肝病（NAFLD）。了解细胞内转运、分泌和细胞外转运所涉及的机制，可能会提供新的信息，这些信息可能适用于针对各种代谢紊乱的治疗靶点。
相似文献
1
Sphingolipids and Lipoproteins in Health and Metabolic Disorders.健康与代谢紊乱中的鞘脂和脂蛋白
Trends Endocrinol Metab. 2017 Jul;28(7):506-518. doi: 10.1016/j.tem.2017.03.005. Epub 2017 Apr 24.
2
Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.脂质在脂蛋白上的运输的分子机制。
Adv Exp Med Biol. 2022;1372:57-65. doi: 10.1007/978-981-19-0394-6_5.
3
Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.鞘脂、胰岛素抵抗与代谢性疾病：鞘脂代谢体内调控的新见解
Endocr Rev. 2008 Jun;29(4):381-402. doi: 10.1210/er.2007-0025. Epub 2008 May 1.
4
Sphingolipids: players in the pathology of metabolic disease.鞘脂类：代谢疾病病理学中的参与者。
Trends Endocrinol Metab. 2009 Jan;20(1):34-42. doi: 10.1016/j.tem.2008.09.004. Epub 2008 Nov 13.
5
A ceramide-centric view of insulin resistance.以神经酰胺为中心的胰岛素抵抗观点。
Cell Metab. 2012 May 2;15(5):585-94. doi: 10.1016/j.cmet.2012.04.002.
6
Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis.微小RNA对鞘脂代谢的调控：一种缓解动脉粥样硬化的潜在方法。
Diseases. 2018 Sep 17;6(3):82. doi: 10.3390/diseases6030082.
7
Sphingolipids in metabolic disease: The good, the bad, and the unknown.代谢性疾病中的神经鞘脂：好的、坏的和未知的。
Cell Metab. 2021 Jul 6;33(7):1293-1306. doi: 10.1016/j.cmet.2021.06.006.
8
Ceramides - Lipotoxic Inducers of Metabolic Disorders.神经酰胺——代谢紊乱的脂毒性诱导剂。
Trends Endocrinol Metab. 2015 Oct;26(10):538-550. doi: 10.1016/j.tem.2015.07.006.
9
Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.胰岛素抵抗及相关代谢紊乱中的神经鞘脂类和磷脂。
Nat Rev Endocrinol. 2017 Feb;13(2):79-91. doi: 10.1038/nrendo.2016.169. Epub 2016 Oct 21.
10
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide.微粒体甘油三酯转运蛋白转运并决定神经酰胺和鞘磷脂而非糖基神经酰胺的血浆浓度。
J Biol Chem. 2015 Oct 23;290(43):25863-75. doi: 10.1074/jbc.M115.659110. Epub 2015 Sep 8.
引用本文的文献
1
Integratomic investigation to assess the liver lipidomic and antiinflammatory activity of lupin protein hydrolysate.采用整合原子研究法评估羽扇豆蛋白水解物的肝脏脂质组学和抗炎活性。
NPJ Sci Food. 2025 Jul 28;9(1):154. doi: 10.1038/s41538-025-00515-7.
2
Reprogramming of liver metabolism during West Nile virus infection unveils novel aspects of disease pathophysiology.西尼罗河病毒感染期间肝脏代谢的重编程揭示了疾病病理生理学的新方面。
Mol Med. 2025 Jul 5;31(1):251. doi: 10.1186/s10020-025-01300-8.
3
Dehydrocostus lactone attenuates atherogenesis by promoting cholesterol efflux and inhibiting inflammation via TLR2/PPAR-γ/NF-κB signaling pathway.去氢木香内酯通过促进胆固醇外流并经由TLR2/PPAR-γ/NF-κB信号通路抑制炎症来减轻动脉粥样硬化的发生。
Mol Med. 2025 Jun 19;31(1):243. doi: 10.1186/s10020-025-01265-8.
4
Hypomagnesemia: exploring its multifaceted health impacts and associations with blood pressure regulation and metabolic syndrome.低镁血症：探讨其多方面的健康影响以及与血压调节和代谢综合征的关联。
Diabetol Metab Syndr. 2025 Jun 16;17(1):217. doi: 10.1186/s13098-025-01772-y.
5
Oral microbiota signatures in obesity with or without acanthosis nigricans in a Chinese cohort.中国队列中伴有或不伴有黑棘皮病的肥胖人群的口腔微生物群特征
J Med Microbiol. 2025 Jun;74(6). doi: 10.1099/jmm.0.002020.
6
Apolipoprotein M expression modifies the sphingolipid landscape in murine blood and lymph.载脂蛋白M的表达改变了小鼠血液和淋巴中的鞘脂格局。
Front Immunol. 2025 May 2;16:1572959. doi: 10.3389/fimmu.2025.1572959. eCollection 2025.
7
Associations of APOE variants with sphingomyelin and cholesterol metabolites across the life-course in diverse populations.不同人群中载脂蛋白E（APOE）变体与鞘磷脂和胆固醇代谢物在生命历程中的关联。
Metabolomics. 2025 May 7;21(3):64. doi: 10.1007/s11306-025-02256-w.
8
The Associations of Maternal Prepregnancy Body Mass Index With Human Milk Fatty Acid and Phospholipid Composition in the Observational Norwegian Human Milk Study.在挪威母乳观察性研究中，孕妇孕前体重指数与母乳脂肪酸和磷脂组成的关联。
J Nutr. 2025 Jun;155(6):1818-1827. doi: 10.1016/j.tjnut.2025.04.009. Epub 2025 Apr 12.
9
Ceramide mediates cell-to-cell ER stress transmission by modulating membrane fluidity.神经酰胺通过调节膜流动性介导细胞间内质网应激传递。
J Cell Biol. 2025 May 5;224(5). doi: 10.1083/jcb.202405060. Epub 2025 Mar 26.
10
Apolipoprotein and sphingolipid measurements: Can be used in the clinical practice of atrial fibrillation diagnosing and evaluating the cryoablation effectiveness?载脂蛋白和鞘脂测量：可用于心房颤动诊断及评估冷冻消融疗效的临床实践吗？
PLoS One. 2025 Mar 4;20(3):e0315905. doi: 10.1371/journal.pone.0315905. eCollection 2025.
本文引用的文献
1
Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia.针对微粒体甘油三酯转移蛋白和脂蛋白组装治疗家族性高胆固醇血症纯合子。
Crit Rev Clin Lab Sci. 2017 Jan;54(1):26-48. doi: 10.1080/10408363.2016.1221883. Epub 2016 Oct 1.
2
Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.鞘脂从头合成：心血管稳态的调节器
Trends Endocrinol Metab. 2016 Nov;27(11):807-819. doi: 10.1016/j.tem.2016.07.005. Epub 2016 Aug 22.
3
Increase of gangliosides in atherosclerotic human aortas.动脉粥样硬化的人类主动脉中神经节苷脂增加。
Lipids. 1975 Apr;10(4):256-9. doi: 10.1007/BF02532490.
4
Sphingomyelin is sorted at the trans Golgi network into a distinct class of secretory vesicle.鞘磷脂在反式高尔基体网络中被分选到一类独特的分泌囊泡中。
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6677-82. doi: 10.1073/pnas.1602875113. Epub 2016 May 31.
5
Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.作为第二信使分子的鞘磷脂-神经酰胺-糖鞘脂途径的化合物：脂肪肝疾病和胰岛素抵抗新疗法的新靶点。
Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1102-17. doi: 10.1152/ajpgi.00095.2016. Epub 2016 May 12.
6
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.血浆神经酰胺可预测稳定型冠状动脉疾病和急性冠状动脉综合征患者的心血管死亡，且独立于低密度脂蛋白胆固醇。
Eur Heart J. 2016 Jul 1;37(25):1967-76. doi: 10.1093/eurheartj/ehw148. Epub 2016 Apr 28.
7
Sphingolipids in High Fat Diet and Obesity-Related Diseases.高脂饮食与肥胖相关疾病中的鞘脂类
Mediators Inflamm. 2015;2015:520618. doi: 10.1155/2015/520618. Epub 2015 Nov 16.
8
Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.载脂蛋白高密度脂蛋白缺陷导致的冠状动脉疾病：通过鞘氨醇-1-磷酸加载进行纠正。
J Am Coll Cardiol. 2015 Sep 29;66(13):1470-85. doi: 10.1016/j.jacc.2015.07.057.
9
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide.微粒体甘油三酯转运蛋白转运并决定神经酰胺和鞘磷脂而非糖基神经酰胺的血浆浓度。
J Biol Chem. 2015 Oct 23;290(43):25863-75. doi: 10.1074/jbc.M115.659110. Epub 2015 Sep 8.
10
Sphingolipids in cardiovascular diseases and metabolic disorders.心血管疾病和代谢紊乱中的鞘脂
Lipids Health Dis. 2015 Jun 16;14:55. doi: 10.1186/s12944-015-0053-y.
Zotero 插件